EZH2 as a Prognostic Factor and Its Immune Implication with Molecular Characterization in Prostate Cancer: An Integrated Multi-Omics in Silico Analysis

Prostate cancer (PCa) is a type of potentially fatal malignant tumor. Immunotherapy has shown a lot of potential for various types of solid tumors, but the benefits have been less impressive in PCa. Enhancer of zeste homolog 2 (EZH2) is one of the three core subunits of the polycomb repressive compl...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Tian-Qi, Liu, Ruifeng, Zhang, Qiuning, Luo, Hongtao, Liu, Zhiqiang, Sun, Shilong, Wang, Xiaohu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687944/
https://www.ncbi.nlm.nih.gov/pubmed/36358967
http://dx.doi.org/10.3390/biom12111617

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687944/
https://www.ncbi.nlm.nih.gov/pubmed/36358967
http://dx.doi.org/10.3390/biom12111617

Ejemplares similares